Previous close | 16.78 |
Open | 16.78 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 500.00 |
Expiry date | 2026-01-16 |
Day's range | 16.78 - 16.78 |
Contract range | N/A |
Volume | |
Open interest | 263 |
Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer have been highlighted in this Industry Outlook article.
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), AstraZeneca (AZN), Pfizer (PFE), Sanofi (SNY) and Bayer (BAYRY) are worth retaining in one's portfolio.
As the United States stock market reaches new heights, buoyed by a robust jobs report and record highs in major indices like the Dow Jones Industrial Average, investors are keenly observing opportunities amid this positive economic sentiment. In such an environment, identifying stocks that might be trading below their fair value can offer potential for growth, especially as the Federal Reserve's monetary policy remains a focal point for market participants.